Companies House · 01027904

JANSSEN-CILAG LIMITED

UK registered company, private limited company, incorporated 19 Oct 1971.

Active
50
Public contracts
51
Spend payments
£1.2m
Total spend

JANSSEN-CILAG LIMITED is a UK company registered at Companies House under number 01027904. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
01027904
Status
Active
Company type
Private Limited Company
Incorporated
19 Oct 1971
Country of origin
United Kingdom
Registered office
50-100 HOLMERS FARM WAY, BUCKINGHAMSHIRE, HP12 4EG
Nature of business (SIC)
21200 - Manufacture of pharmaceutical preparations
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to JANSSEN-CILAG LIMITED.

ProcurementBuyerAwardedValue
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
NP30925 Psychiatry and Neurology MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP30925 Psychiatry and Neurology MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025NHS England
Biologic and Biosimilar MedicineseTenderwales
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) 1 Nov 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
NP47924 Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Project title: NHS National Framework for Golimumab Injection commencing 1st November 2025NHS England
Medicinal Products Dynamic Purchasing System (131864)Procurement and Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
Project title: NHS National Framework for Golimumab Injection commencing 1st November 2025NHS England25 Aug 2025£60m
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025NHS England30 Jun 2025£986.3m
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024NHS England28 Oct 2024£626.5m
CM/TNS/24/5711 -NHS Framework for the supply of UstekinumabNHS England12 Aug 2024£230m
NHS Branded Medicines Tranche Framework for London and South of EnglandNHS England21 Jul 2024£381m
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)NHS England4 Mar 2024£1
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS South of England Branded Medicines - Tranche A - September 2023NHS England17 Jul 2023£249.8m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD6 Jul 2023£428.2m
NHS Framework Agreement-Branded Medicines - National Proprietary PharmaceuticalsNHS England23 Apr 2023£304.5m
NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone InjectionNHS england27 Mar 2023£27m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m
NHS Framework Agreement for Branded medicines - NationalNHS England15 May 2022£526m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for Midlands and East, Branded Medicines - Tranche A and AnnualNHS England7 Feb 2022£216.1m
National Procurement for HIV and Preventative TreatmentsNHSE&I1 Feb 2022£230m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework, North of England, Branded Medicines-Tranche A and Annual TrancheNHS England11 Feb 2021£1
NHS Framework for the Midlands and East, Branded Medicines - Tranche BNHS England25 Jan 2021£228.2m
NHS National Pharmaceuticals - Fulvestrant, Darunavir and ImatinibNHS England4 Jan 2021£17.3m
NHS Framework for the NHS London Region, Branded Medicines - Tranche ANHS England16 Jun 2020£191.1m

Supplier identities

How this company appears as a supplier across the data.

Recent transparency payments

51 payments recorded, totalling £1,161,938.

PayerDescriptionDateAmount
salisbury-nhs-foundation-trustDRUGS27 Apr 2020£37k
salisbury-nhs-foundation-trustDRUGS27 Apr 2020£7.4k
salisbury-nhs-foundation-trustDRUGS3 Apr 2020£24.5k
salisbury-nhs-foundation-trustDRUGS3 Apr 2020£4.9k
salisbury-nhs-foundation-trustDRUGS21 Feb 2020£5.6k
salisbury-nhs-foundation-trustDRUGS21 Feb 2020£27.9k
united-lincolnshire-hospitals-nhs-trustGRANTHAM PHARMACY CREDITORS5 Sept 2019£27.8k
united-lincolnshire-hospitals-nhs-trustPHARMACY PILGRIM5 Sept 2019£33.1k
salisbury-nhs-foundation-trustDRUGS30 Aug 2019£29.1k
salisbury-nhs-foundation-trustDRUGS30 Aug 2019£5.8k
united-lincolnshire-hospitals-nhs-trustPHARMACY PILGRIM14 Aug 2019£35.9k
united-lincolnshire-hospitals-nhs-trustPHARMACY PILGRIM31 Jul 2019£27.7k
united-lincolnshire-hospitals-nhs-trustPHARMACY PILGRIM24 Jul 2019£30.2k
salisbury-nhs-foundation-trustDRUGS30 May 2019£29.1k
salisbury-nhs-foundation-trustDRUGS30 May 2019£5.8k
salisbury-nhs-foundation-trustDRUGS16 May 2019£5.2k
salisbury-nhs-foundation-trustDRUGS16 May 2019£26.1k
salisbury-nhs-foundation-trustDRUGS1 May 2019£22.2k
salisbury-nhs-foundation-trustDRUGS1 May 2019£4.4k
salisbury-nhs-foundation-trustDRUGS7 Dec 2018£4.7k
salisbury-nhs-foundation-trustDRUGS7 Dec 2018£23.5k
salisbury-nhs-foundation-trustDRUGS18 Oct 2018£4.6k
salisbury-nhs-foundation-trustDRUGS18 Oct 2018£23.1k
salisbury-nhs-foundation-trustDRUGS30 Aug 2018£22.2k
salisbury-nhs-foundation-trustDRUGS30 Aug 2018£4.4k

FAQs about JANSSEN-CILAG LIMITED

Is JANSSEN-CILAG LIMITED an active company?

JANSSEN-CILAG LIMITED (company number 01027904) is recorded as "Active", incorporated on 19 Oct 1971.

What does JANSSEN-CILAG LIMITED do?

Its Companies House nature-of-business (SIC) is: 21200 - Manufacture of pharmaceutical preparations.

Has JANSSEN-CILAG LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

How much public money has JANSSEN-CILAG LIMITED received?

51 transparency-spend payments totalling £1,161,938 are recorded against JANSSEN-CILAG LIMITED.

Where is JANSSEN-CILAG LIMITED based?

Its registered office is 50-100 HOLMERS FARM WAY, BUCKINGHAMSHIRE, HP12 4EG.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable